The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Bevacizumab in first-line chemotherapy to improve the survival outcome for advanced ovarian clear cell carcinoma: A multicenter, retrospective analysis.
 
Toshiyuki Seki
No Relationships to Disclose
 
Shinichi Tate
No Relationships to Disclose
 
Kyoko Nishikimi
No Relationships to Disclose
 
Yoichi Unno
No Relationships to Disclose
 
Mizue Itoi
No Relationships to Disclose
 
Sadatomo Ikeda
No Relationships to Disclose
 
Nobuhisa Yoshikawa
No Relationships to Disclose
 
Hidehiko Akashi
No Relationships to Disclose
 
Eitaro Suzuki
No Relationships to Disclose
 
Naotake Tanaka
No Relationships to Disclose
 
Takashi Hirakawa
No Relationships to Disclose
 
Hiroaki Kajiyama
No Relationships to Disclose
 
Hirokuni Takano
No Relationships to Disclose
 
Kosuke Yoshihara
No Relationships to Disclose
 
Aikou Okamoto
Honoraria - AstraZeneca Japan; Chugai Pharma; Eisai; Kaken Pharmaceutical; MSD; Takeda; Zeria Pharmaceutical
Speakers' Bureau - AstraZeneca Japan
Research Funding - ASKA Pharmaceutical Co., Ltd. (Inst); AstraZeneca Japan (Inst); Chugai Pharma (Inst); Daiichi Sankyo Co., Ltd. (Inst); Eisai (Inst); Fuji Pharma (Inst); Gyne Mom Co. (Inst); Kaken Pharmaceutical (Inst); Kissei Pharmaceutical (Inst); Linical (Inst); Meiji holdings (Inst); Mochida Pharmaceutical Co. Ltd. (Inst); MSD K.K. (Inst); Nippon Shinyaku (Inst); Pfizer (Inst); Shinnihonseiyaku (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst); TERUMO (Inst); Tsumura & Co. (Inst)
 
Makio Shozu
No Relationships to Disclose